Clearstream’s core business areas experienced further growth during April 2005 with the value of assets held in custody on behalf of customers rising to EUR 7.9 trillion, a rise of 2.6 percent from the end of the same month last year (April 2004 EUR 7.7 trillion). The number of international transactions processed by Clearstream also rose to 1.60 million for the month representing a rise of 10.3 percent compared with the same month last year (April 2004: 1.45 million). Of these transactions, 15 percent are registered as stock exchange transactions, 85 percent are Over the Counter (OTC) transactions. For domestic settlement transactions in Germany, the figure stood at 2.70 million in April 2005 representing a decrease of 10.6 percent on the same period last year (April 2004: 3.02 million). The ratio for domestic settlement transactions was 66 percent stock exchange transactions to 34 percent OTC transactions.
Within the Global Securities Financing services business, strong growth continued with the monthly average outstandings reaching EUR 177.2 billion. The combined services include tripartite repo, securities lending and collateral management and collectively experienced a rise of over 38.4 percent from the same month last year (April 2004: EUR 128.0 billion).
Clearstream’s investment funds service called Vestima+ showed further volume increases with the number of investment funds related instructions processed reaching 170,146 in April 2005, a rise of 21.2 percent from the same month last year (April 2004: 140,341).
Yolande Theis and Graham Cope will be happy to answer questions from the news desks: phone +352-243-31500
Media Relations | Deutsche Boerse Group
How Strong Brands Translate into Money
15.11.2016 | Kühne Logistics University - Wissenschaftliche Hochschule für Logistik und Unternehmensführung
Demographic change depresses tax revenues
04.11.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences